Mpt Mustard Products & Technologies Inc.

Canopy Growth Corporation

Nuseed Global Innovation Ltd.

Agrisoma Biosciences Inc.

Fytoken Products, Inc.

Mark Hetherington

Michael Lindenbaum

James Robinson

Travis Hoffman

Jason Green

Warren Steck

A process to remove the glucosinolates of oilseed meals, such asoilseed meals, is provided. In one embodiment, exogenous myrosinase is used to convert the glucosinolates to volatile isothiocyanate compounds, which can then be removed under conditions of mild heat and negative pressure. In another embodiment, heat and pressure are used to remove glucosinolates fromoilseed. The processed meals may contain less than 80% of their starting levels of glucosinolates and may be suitable for use in various applications, including as animal feeds.

Method for removing glucosinolates from oilseed meals

Compositions and methods for the prevention and treatment of anxiety conditions associated with the use ofare disclosed herein. The medicinal compositions include cannabidiol or cannabidiolic acid and one or more of the following compounds: bergamottin or dihydroxybergamottin, phloretin or a phloretin glycoside, piperine, apigenin or an apigenin glycoside and ursolic acid.

Method for treating cannabis induced anxiety

Provided are pesticide application kits comprising a liquid formulation comprising a glucosinolate concentrate, an active myrsoinase enzyme complex, and a water soluble polyol. Further included in the kits are instructions for the addition of water to form a diluted formulation, and application of the diluted formulation to a pest.

Kits comprising biopesticide compositions comprising myrosinase, glucosinolates and water soluble polyols

Provided are liquid compositions comprising inactive biopesticide precursors comprising a glucosinolate concentrate, a plant material comprising a myrosinase enzyme complex, and a water soluble polyol. Further provided are methods of making and using such compositions.

Biopesticide compositions comprising water soluble polyols

The invention provides medicaments comprising an oenothein, including topical formulations for use as free radical scavengers, or to treat irritation, or to treat inflammation. The oenothein for use in such formulations, such as oenothein-A or oenothein-B, may be purified from natural sources, such as plant material (e.g. ).

Growing community of inventors

Saskatoon, Canada

Mark Hetherington